Proteomic expression analysis and comparison of protein and mRNA expression profiles in human malignant gliomas

Proteomics - Clinical Applications

Volumn 3, Issue 1, 2009, Pages 83-94

  Persson, Oscar ^a   Brynnel, Ulrika ^b   Levander, Fredrik ^b   Widegren, Bengt ^a,b   Salford, Leif G ^a   Krogh, Morten ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

2 D DIGE; Glioma; Signaling pathways

Indexed keywords

ACTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KERATIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RAF PROTEIN; SUPEROXIDE DISMUTASE; VIMENTIN;

ANALYTIC METHOD; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; GENE EXPRESSION PROFILING; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROARRAY ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

EID: 65549152377     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800086     Document Type: Article

References (45)

1. CBTRUS, Statistical Report: Primary Brain Tumors in the United States, 1998-2002, Published by the Central Brain Tumor Registry of the United States, 2005.
2. Kleihues, P., Cavenee, W. K., Pathology and Genetics of Tumours of the Nervous System, International Agency for Research on Cancer, Lyon, France 2000.
3. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M. et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987-996.
4. Ohgaki, H., Kleihues, P., Epidemiology and etiology of gliomas. Acta Neuropathol. (Berl.) 2005, 109, 93-108.
5. Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H. et al., Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J. Clin. Oncol. 2002, 20, 1389-1397.
6. Sampson, J. H., Akabani, G., Archer, G. E., Bigner, D. D. et al., Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J. Neurooncol. 2003, 65, 27-35.
7. Salford, L., Ask, E., Siesjo, P., Skagerberg, G. et al., Immunization with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in GBM-patients older than 50 years. Neuro-Oncology 2005, 7, 370.
8. Steiner, H. H., Bonsanto, M. M., Beckhove, P., Brysch, M. et al., Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefit. J. Clin. Oncol. 2004, 22, 4272-4281.
9. Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A. et al., Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA 2000, 97, 12846-12851.
10. Glass, R., Synowitz, M., Kronenberg, G., Walzlein, J. H. et al., Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J. Neurosci. 2005, 25, 2637-2646.
11. Persson, O., Krogh, M., Saal, L. H., Englund, E. et al., Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets. J. Neurooncol. 2007, 85, 11-24.
12. Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F. et al., Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9, 157-173.
13. Mischel, P. S., Cloughesy, T. F., Nelson, S. F., DNA-microarray analysis of brain cancer: Molecular classification for therapy. Nat. Rev. Neurosci. 2004, 5, 782-792.
14. Chumbalkar, V. C., Subhashini, C., Dhople, V. M., Sundaram, C. S. et al., Differential protein expression in human gliomas and molecular insights. Proteomics 2005, 5, 1167-1177.
15. Iwadate, Y., Sakaida, T., Hiwasa, T., Nagai, Y. et al., Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res. 2004, 64, 2496-2501.
16. Tso, C. L., Freije, W. A., Day, A., Chen, Z. et al., Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res. 2006, 66, 159-167.
17. Back, P., Nagard, F., Bolmsjo, G., Bengtsson, S., James, P., Automating gel image acquisition. J. Proteome Res. 2003, 2, 662-664.
18. Back, P., Bengtsson, S., James, P., Automated prescan function for scanning fluorescently stained 2D-PAGE gels. J. Proteome Res. 2005, 4, 1511-1515.
19. Levander, F., Krogh, M., Warell, K., Garden, P. et al., Automated reporting from gel-based proteomics experiments using the open source Proteios database application. Proteomics 2007, 7, 668-674.
20. Craig, R., Beavis, R. C., TANDEM: Matching proteins with tandem mass spectra. Bioinformatics 2004, 20, 1466-1467
21. Cristianini, N., Shawe-Taylor, J., An Introduction to Support Vector Machines, Cambridge University Press, Cambridge, UK 2000.
22. Chang, C.-C., Lin, C.-J., LIBSVM: A Library for Support Vector Machines, Software available at http://www.csie.ntu.edu.tw/~cjlin/ libsvm, 2001.
23. Ihaka, R., Gentleman, R., R: A language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5, 299-314.
24. Ringner, M., Veerla, S., Andersson, S., Staaf, J., Hakkinen, J., ACID: A database for microarray clone information. Bioinformatics 2004, 20, 2305-2306.
25. Breslin, T., Eden, P., Krogh, M., Comparing functional annotation analyses with Catmap. BMC Bioinformatics 2004, 5, 193.
26. Janosch, P., Kieser, A., Eulitz, M., Lovric, J. et al., The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. Faseb. J. 2000, 14, 2008-2021.
27. Chakravarti, A., Delaney, M. A., Noll, E., Black, P. M. et al., Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin. Cancer Res. 2001, 7, 2387-2395.
28. Li, A., Walling, J., Kotliarov, Y., Center, A. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol. Cancer Res. 2008.
29. Chen, Y. R., Juan, H. F., Huang, H. C., Huang, H. H. et al., Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. J. Proteome Res. 2006, 5, 2727-2742.
30. Juan, H. F., Lin, J. Y., Chang, W. H., Wu, C. Y. et al., Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 2002, 23, 2490-2504.
31. Fukata, Y., Itoh, T. J., Kimura, T., Menager, C. et al., CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 2002, 4, 583-591.
32. Vincent, P., Collette, Y., Marignier, R., Vuaillat, C. et al., A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J. Immunol. 2005, 175, 7650-7660.
33. Chen, A., Liao, W. P., Lu, Q., Wong, W. S., Wong, P. T., Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochem. Int. 2007, 50, 1078-1086.
34. Greene, N. D., Bamidele, A., Choy, M., de Castro, S. C. et al., Proteome changes associated with hippocampal MRI abnormalities in the lithium pilocarpine-induced model of convulsive status epilepticus. Proteomics 2007, 7, 1336-1344.
35. McNally, L. M., Yee, L., McNally, M. T., Heterogeneous nuclear ribonucleoprotein H is required for optimal U11 small nuclear ribonucleoprotein binding to a retroviral RNA-processing control element: implications for U12-dependent RNA splicing. J. Biol. Chem. 2006, 281, 2478-2488.
36. Kobori, N., Clifton, G. L., Dash, P., Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res. Mol. Brain Res. 2002, 104, 148-158.
37. App, H., Hazan, R., Zilberstein, A., Ullrich, A. et al., Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor. Mol. Cell. Biol. 1991, 11, 913-919.
38. Kolch, W., Meaningful relationships: The regulation of the Ras/Raf/MEK/ ERK pathway by protein interactions. Biochem. J. 2000, 351 Pt 2, 289-305.
39. Light, Y., Paterson, H., Marais, R., 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Mol. Cell. Biol. 2002, 22, 4984-4996.
40. Tzivion, G., Luo, Z., Avruch, J., A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 1998, 394, 88-92.
41. Wu, K. L., Khan, S., Lakhe-Reddy, S., Jarad, G. et al., The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem. 2004, 279, 26280-26286.
42. Majores, M., Schick, V., Engels, G., Fassunke, J. et al., Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions. Acta Neuropathol. 2005, 110, 537-546.
43. De Corte, V., Bruyneel, E., Boucherie, C., Mareel, M. et al., Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO. J. 2002, 21, 6781-6790.
44. Gdynia, G., Grund, K., Eckert, A., Bock, B. C. et al., Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol. Cancer Res. 2007, 5, 1232-1240.
45. Jung, C. S., Foerch, C., Schanzer, A., Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 2007, 130, 3336-3341